Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Operational Highlights
LH logo

Labcorp Achieves 8.6% Revenue Growth and 16.3% Margin Expansion in Q3 2025

LH10-QFiling Date: 10/31/2025
Labcorp Holdings Inc.
Description

What this story covers

Labcorp's Q3 2025 10-Q shows 8.6% revenue growth to $3.56B, driven by Diagnostics (78% of revenues) and Biopharma segments. Operating income up 56.1%, with strong cash flows of $1.03B. Strategic acquisitions enhance genetics and market reach; hedges mitigate FX and rate risks amid stable liquidity.

Story snapshot

CompanyLabcorp Holdings Inc.
TickerLH
VariantStandard detailed
Duration13:10
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0000920148-25-000096

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in